Biotechnology Assets is a biotechnology group strategically focused on the ‘One Health’ concept which encompasses human and animal health. Subsidiaries and a global commercial structure devoted to the monetisation of their different high-valued assets. Depending on their field of application, these assets can be categorised as follows: 1) detection / diagnosis, 2) prevention, 3) therapeutic, 4) fermentation ingredients.
 
The Group's main strategy is to foster its commercial network in order to leverage the organic growth of its assets while evaluating opportunities of inorganic growth in the biotechnology field.